CID 16204657

5'-ttgtgggcg-3'

Structural Information

Molecular Formula
C89H113N34O49P9S9
SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)O)OP(=S)(O)OCC3C(CC(O3)N4C=C(C(=O)NC4=O)C)OP(=S)(O)OCC5C(CC(O5)N6C=NC7=C6N=C(NC7=O)N)OP(=S)(O)OCC8C(CC(O8)N9C=C(C(=O)NC9=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)O)S
InChI
InChI=1S/C89H113N34O49P9S9/c1-32-15-116(87(134)112-73(32)125)56-8-37(45(158-56)19-147-173(137,138)182)166-175(140,184)150-21-47-38(9-57(159-47)117-16-33(2)74(126)113-88(117)135)167-176(141,185)152-23-49-41(12-60(161-49)121-29-98-65-70(121)104-83(93)109-78(65)130)170-179(144,188)151-22-48-39(10-58(160-48)118-17-34(3)75(127)114-89(118)136)168-177(142,186)153-24-50-42(13-61(162-50)122-30-99-66-71(122)105-84(94)110-79(66)131)171-180(145,189)155-26-52-43(14-62(164-52)123-31-100-67-72(123)106-85(95)111-80(67)132)172-181(146,190)154-25-51-40(11-59(163-51)120-28-97-64-69(120)103-82(92)108-77(64)129)169-178(143,187)149-20-46-36(7-55(157-46)115-5-4-53(90)101-86(115)133)165-174(139,183)148-18-44-35(124)6-54(156-44)119-27-96-63-68(119)102-81(91)107-76(63)128/h4-5,15-17,27-31,35-52,54-62,124H,6-14,18-26H2,1-3H3,(H,139,183)(H,140,184)(H,141,185)(H,142,186)(H,143,187)(H,144,188)(H,145,189)(H,146,190)(H2,90,101,133)(H,112,125,134)(H,113,126,135)(H,114,127,136)(H2,137,138,182)(H3,91,102,107,128)(H3,92,103,108,129)(H3,93,104,109,130)(H3,94,105,110,131)(H3,95,106,111,132)
InChIKey
HNEJGTFGNKXUJF-UHFFFAOYSA-N
Compound name
1-[4-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-sulfanylphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(dihydroxyphosphinothioyloxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

3008.252 Da
Monoisotopic Mass

-5.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 3009.2593 293.2
[M+Na]+ 3031.2412 297.9
[M-H]- 3007.2447 294.0
[M+NH4]+ 3026.2858 295.0
[M+K]+ 3047.2152 295.5
[M+H-H2O]+ 2991.2493 293.7
[M+HCOO]- 3053.2502 295.2
[M+CH3COO]- 3067.2659 295.6
[M+Na-2H]- 3029.2267 298.6
[M]+ 3008.2515 297.6
[M]- 3008.2525 297.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.